Cecilia J. Tsang

Array ( [id] => 2493699 [patent_doc_number] => 04843158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-06-27 [patent_title] => '[2,2,1]Cryptand compounds that selectively bind sodium' [patent_app_type] => 1 [patent_app_number] => 6/932643 [patent_app_country] => US [patent_app_date] => 1986-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6153 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/843/04843158.pdf [firstpage_image] =>[orig_patent_app_number] => 932643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2385202 [patent_doc_number] => 04737499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-04-12 [patent_title] => 'Ergotalkaloids for treating senile dementia' [patent_app_type] => 1 [patent_app_number] => 6/932075 [patent_app_country] => US [patent_app_date] => 1986-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5171 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/737/04737499.pdf [firstpage_image] =>[orig_patent_app_number] => 932075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2452093 [patent_doc_number] => 04723003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-02-02 [patent_title] => 'Benzopyrrolobenzodiazepines and quinobenzodiazepines' [patent_app_type] => 1 [patent_app_number] => 6/929697 [patent_app_country] => US [patent_app_date] => 1986-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30128 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/723/04723003.pdf [firstpage_image] =>[orig_patent_app_number] => 929697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2452197 [patent_doc_number] => 04723007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-02-02 [patent_title] => 'Benzopyrrolobenzodiazepines and quinobenzodiazepines' [patent_app_type] => 1 [patent_app_number] => 6/929705 [patent_app_country] => US [patent_app_date] => 1986-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30128 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/723/04723007.pdf [firstpage_image] =>[orig_patent_app_number] => 929705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2411811 [patent_doc_number] => 04761412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-08-02 [patent_title] => 'Benzopyrrolobenzodiazepines and quinobenzodiazepines useful for the treatment of psychoses' [patent_app_type] => 1 [patent_app_number] => 6/929700 [patent_app_country] => US [patent_app_date] => 1986-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30104 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/761/04761412.pdf [firstpage_image] =>[orig_patent_app_number] => 929700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2391123 [patent_doc_number] => 04764616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-08-16 [patent_title] => 'Benzopyrrolobenzodiazepines and quinobenzodiazepines' [patent_app_type] => 1 [patent_app_number] => 6/929696 [patent_app_country] => US [patent_app_date] => 1986-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30194 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/764/04764616.pdf [firstpage_image] =>[orig_patent_app_number] => 929696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2416339 [patent_doc_number] => 04742171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-03 [patent_title] => 'Method of synthesizing 1,4-dihydro-benzo[c]-1,5-naphthyridin-2(3H)-ones' [patent_app_type] => 1 [patent_app_number] => 6/926752 [patent_app_country] => US [patent_app_date] => 1986-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9249 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/742/04742171.pdf [firstpage_image] =>[orig_patent_app_number] => 926752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2395588 [patent_doc_number] => 04769459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-09-06 [patent_title] => 'Oxidative imaging' [patent_app_type] => 1 [patent_app_number] => 6/926338 [patent_app_country] => US [patent_app_date] => 1986-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8210 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/769/04769459.pdf [firstpage_image] =>[orig_patent_app_number] => 926338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2420596 [patent_doc_number] => 04748247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-31 [patent_title] => '2-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]alkyl]alkyl]pyrido- and pyrazino-indole-1,3-dione derivatives as histamine H.sub.1 antagonists' [patent_app_type] => 1 [patent_app_number] => 6/921642 [patent_app_country] => US [patent_app_date] => 1986-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1322 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/748/04748247.pdf [firstpage_image] =>[orig_patent_app_number] => 921642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2446595 [patent_doc_number] => 04791111 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-12-13 [patent_title] => '[[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]- 1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties' [patent_app_type] => 1 [patent_app_number] => 6/919400 [patent_app_country] => US [patent_app_date] => 1986-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17098 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 503 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/791/04791111.pdf [firstpage_image] =>[orig_patent_app_number] => 919400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2927111 [patent_doc_number] => 05219621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Methods of treatment with diltiazem formulations' [patent_app_type] => 1 [patent_app_number] => 6/918925 [patent_app_country] => US [patent_app_date] => 1992-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6234 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219621.pdf [firstpage_image] =>[orig_patent_app_number] => 918925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2927111 [patent_doc_number] => 05219621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Methods of treatment with diltiazem formulations' [patent_app_type] => 1 [patent_app_number] => 6/918925 [patent_app_country] => US [patent_app_date] => 1992-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6234 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219621.pdf [firstpage_image] =>[orig_patent_app_number] => 918925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2386415 [patent_doc_number] => 04775756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-10-04 [patent_title] => '5-(4-amino-3,5-dimethoxyphenyl)-5-hydroxy-barbituric acid' [patent_app_type] => 1 [patent_app_number] => 6/917567 [patent_app_country] => US [patent_app_date] => 1986-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1561 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/775/04775756.pdf [firstpage_image] =>[orig_patent_app_number] => 917567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2540934 [patent_doc_number] => 04826851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-05-02 [patent_title] => '2-substituted ergoline urea and thio-urea derivatives having neurolyptic/dopaminergic activity' [patent_app_type] => 1 [patent_app_number] => 6/915356 [patent_app_country] => US [patent_app_date] => 1986-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3923 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/826/04826851.pdf [firstpage_image] =>[orig_patent_app_number] => 915356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2516904 [patent_doc_number] => 04874768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-10-17 [patent_title] => '1,2-disubstituted ergolines useful for producing central antidopanminergic or .alpha.2-receptor-blocking activity' [patent_app_type] => 1 [patent_app_number] => 6/915358 [patent_app_country] => US [patent_app_date] => 1986-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5670 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/874/04874768.pdf [firstpage_image] =>[orig_patent_app_number] => 915358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2390752 [patent_doc_number] => 04754043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-06-28 [patent_title] => 'Oxazole and thiazole naphthalenes as antiallergic agents' [patent_app_type] => 1 [patent_app_number] => 6/915444 [patent_app_country] => US [patent_app_date] => 1986-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3869 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/754/04754043.pdf [firstpage_image] =>[orig_patent_app_number] => 915444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2425547 [patent_doc_number] => 04774336 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-09-27 [patent_title] => 'Process for preparing N-substituted piperazines from ethylene glycol and amines' [patent_app_type] => 1 [patent_app_number] => 6/914224 [patent_app_country] => US [patent_app_date] => 1986-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2445 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/774/04774336.pdf [firstpage_image] =>[orig_patent_app_number] => 914224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2385152 [patent_doc_number] => 04737496 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-04-12 [patent_title] => '1,3,4,16b-tetra hydro-2H,10H-indolo[2,1-c]pyrazino-[1,2-a][1,4]benzodiazepines useful as serotonin-2 receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 6/914028 [patent_app_country] => US [patent_app_date] => 1986-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10872 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/737/04737496.pdf [firstpage_image] =>[orig_patent_app_number] => 914028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2425530 [patent_doc_number] => 04774335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-09-27 [patent_title] => 'Production process for thiocyanopyrimidine' [patent_app_type] => 1 [patent_app_number] => 6/910661 [patent_app_country] => US [patent_app_date] => 1986-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6210 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/774/04774335.pdf [firstpage_image] =>[orig_patent_app_number] => 910661 [rel_patent_id] =>[rel_patent_doc_number] =>)